DSM Biologics, a business unit of DSM Pharmaceutical Products, and Upfront Chromatography have announced the collaboration between the two companies to optimize Upfront's new, fully disposable chromatography system for use with DSM's proprietary manufacturing technology.
Subscribe to our email newsletter
The combination of Upfront’s unique disposable chromatography system and DSM’s proprietary manufacturing technology will reportedly deliver a flexible, easy-to-use and high-capacity bioprocessing platform that can be scaled from 0.1L to 100L for commercial manufacture and recovery of a range of biopharmaceuticals, including monoclonal antibodies.
Michael Bennett, CEO of Upfront said: “The biopharmaceutical industry has been seeking fully disposable chromatography systems over recent years. Our technology offers manufacturers all the productivity benefits they expect from industrial-scale chromatography systems and with DSM Biologics we have the perfect partner to drive this combination of disposable systems and high-yield cell lines to market.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.